“Differential Cardiometabolic Effects of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Early-Onset Type 2 Diabetes: A Randomized Controlled Trial”. 2026. Link Medical Journal 4 (1): 1-9. https://doi.org/10.61919/061x6w21.